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ABSTRACT
Background and purpose - CADASIL is an inherited small-vessel disease responsible for lacunar
strokes and cognitive impairment. The disease is caused by highly stereotyped mutations in Notch3,
expression of which is highly restricted to vascular smooth muscle cells (vSMC). The underlying
vasculopathy is characterized by degeneration of vSMC and the accumulation of granular osmiophilic
material (GOM) and Notch3 protein within the cell surface of these cells. In this study we assessed
early functional changes related to the expression of mutant Notch3 in resistance arteries.
Methods –Vasomotor function was examined in vitro in arteries from transgenic mice that express a
mutant Notch3 in vSMC. Tail artery segments from transgenic and normal wild-type male mice were
mounted on small-vessel arteriographs and reactivity to mechanical (flow and pressure) forces and
pharmacological stimuli were determined. Mice were studied at 10-11 months of age when vSMC
degeneration, GOM deposits and Notch3 accumulation were not yet present.
Results - Passive arterial diameter, contraction to phenylephrine and endothelium-dependent
relaxation to acetylcholine were unaffected in transgenic mice. By contrast, flow-induced dilation was
significantly decreased and pressure-induced myogenic tone significantly increased in arteries from
transgenic mice compared with wild-type mice.
Conclusions – This is the first study providing evidence that mutant Notch3 impairs selectively the
response of resistance arteries to flow and pressure. The data suggest an early role of vascular
dysfunction in the pathogenic process of the disease.
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2INTRODUCTION
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy) is an inherited small vessel disease characterized by recurrent ischemic
strokes, cognitive impairment and premature death1-3. On neuropathological examination, brains
show a diffuse myelin loss and multiple small deep infarcts located within the white matter and
basal ganglia. These changes are caused by a distinctive arteriopathy characterized by a progressive
degeneration of vascular smooth muscle cells (vSMC) and the accumulation of granular osmiophilic
material (GOM) within the basement membrane of these cells. Arterial changes are systemic
although symptoms are restricted to the central nervous system4-5.
CADASIL is caused by highly stereotyped mutations in the Notch3 receptor, which lead to an odd
number of cysteine residues within an Epidermal Growth Factor Repeat (EGFR) of the extracellular
domain6-9. Recent works demonstrated that vSMC are the primary targets of the pathogenic process.
In human adults, expression of Notch3 is highly restricted to vSMC. In CADASIL, there is an
abnormal accumulation of Notch3 at the plasma membrane of vSMC because of an impaired
clearance of the receptor1 0. Consistent with these data, transgenic mice that express a mutant Notch3 in
vSMC develop arterial lesions similar to that seen in CADASIL patients1 1.
Functional consequences of vessel changes in the CADASIL pathogenesis process remain to be
elucidated. In CADASIL patients, two types of lesions affecting resistance arteries have been
described that might affect hemodynamic. First, narrowing of the arterial lumen may reduce the
baseline blood flow. Second, degeneration of vSMC may impair the vasomotor function. Analysis of
transgenic mice that express a mutant Notch3 revealed a third type of lesions that precede vSMC
degeneration, GOM deposits and Notch3 accumulation. These changes are characterized the
disruption of anchorage and adhesion of vSMC to neighboring cells as well as cytoskeleton
abnormalities of vSMC11. Flow (shear stress) is the main mechanical stimulus activating vascular
endothelial cells whereas pressure is the main mechanical stimulus responsible for a sustained
vasoconstrictor (myogenic) tone in resistance arteries12-13. We and others have previously shown that
vascular mechanotransduction to shear stress and tensile stress relies on the integrity of cytoskeletal
proteins and intercellular communications 12-17. On the basis of the aforementioned observations, we
hypothesized that these early vascular changes may impair vasomotor function. In the present work,
we assessed the vascular reactivity in response to vasoactive agents and mechanical forces in isolated
arteries from transgenic mice expressing the Arg90Cys mutant Notch3 protein and wild-type
littermates mice. We studied mice at 10 months of age when vSMC cytoskeleton and adhesion defects
were present but GOM deposits, Notch3 accumulation and vSMC degeneration were absent. We
focused on the tail caudal arteries because alterations have been especially well characterized in these
vessels1 1.
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3METHODS
Animals
The transgenic mouse model of CADASIL arteriopathy used in this study has been described
previously1 1. In brief, transgenic mice express a mutant human Notch3, carrying the arginine-to
cysteine mis-sense mutation at amino acid position 90 in the EGFR n°2, with the expression driven by
the SM22a promoter. Two independent transgenic founder lines (TgMa and TgVe) that express a low
level of mutant Notch3 (< 50% of murine Notch3) in the tail arteries have been established, with TgVe
expressing a higher level than TgMa. Male transgenic mice heterozygous for the transgene and their
wild-type littermates were used. All mice were studied at 10-11 months when vSMC degeneration,
GOM deposits and Notch3 accumulation were not yet detected.
The procedure followed in the care and euthanasia of the study animals was in accordance with the
European Community Standards on the Care and Use of Laboratory Animals (Ministère de
l’Agriculture and Préfecture de Paris, authorizations 00577 and 75-071).
Determination of blood pressure
Blood pressure was measured by direct intra-arterial recording. Tygon catheter was inserted into the
femoral artery on anesthetized mice with inhaled halothane. Mouse was allowed to recover from
anesthesia and held under minimal restraint. Rectal temperature was maintained at 37 °-37.7C. Heart
rate and blood pressure were monitored using a 4-Multichannel recorder (Gould RS 3400).
Vascular Function
Mice were anesthetized with an intraperitoneal injection of pentobarbital sodium (75 to 100 mg/kg).
Tail caudal arteries were removed and cannulated at both ends in a video-monitored perfusion system
(LSI, Burlington, VT) as previously described15,18. Briefly, arteries were bathed in a 5 ml organ bath
containing physiological salt solution of the following composition (in mM) : 135.0, NaCl, 15.0,
NaHCO3, 4.6 KCl, 1.5, CaCl2, 1.2, MgSO4, 11.0, glucose, 5.0, N-2-hydroxy-ethylpiperazine-N-2-
ethylsulfonic acid. The pH was 7.4. The pO2 was maintained at a value of 160 mmHg and the pCO2
at a value of 37 mmHg. The bath solution was changed continuously at a rate of 4 ml min-1. (pH 7.4,
pO2 160 mmHg, pCO2 37 mmHg). Perfusion of the artery was achieved with a similar physiological
salt solution. Pressure was controlled by a servo-perfusion system and flow was generated by  a
peristaltic pump. Flow-induced dilation was studied by increasing flow rate by steps from 0 to 50 µl.
min-1. Data were obtained from arterial segments preconstricted with phenylephrine to approximately
50% to 60% of maximum response and with intraluminal pressure set at 75 mmHg as described1 4.
Myogenic tone was determined by increasing intraluminal pressure by steps from 10 to 150 mmHg
without intraluminal flow1 5.
Diameters measured in normal physiological salt solution were considered as diameter under active
tone or "active diameter" At the end of each experiment arterial segments were superfused with a
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and pressure steps were repeated in order to determine the arteries’ passive diameter1 4.
Results are given in micrometers for artery diameters. Myogenic tone was expressed as active tone
(passive diameter - active diameter, in µm) or as the percentage of passive diameter (measured
diameter/passive diameter X 100). Flow-induced relaxation was expressed as increase in diameter
(µm) as a function of shear stress due to flow in each vessel. Shear stress was calculated for each
individual segment of artery as previously described13-15 {τ = 4 η . Q/ π  . r3, where h is viscosity
(poise = dyn . s . cm-2), Q is flow (ml/s), and r is radius (cm)}.
In a separate series of arterial segments, we examined dose-dependent contraction of tail arterial
segments in response to phenylephrine (10 nmol/L to 1 mmol/L) and relaxation in response to
acetylcholine (10 nmol/L to 100 µmol/L) after precontraction with phenylephrine (50% of the
maximal contraction) as previously described1 5. Contraction in response to phenylephrine was
expressed as change in diameter (µm) due to phenylephrine. Relaxation in response to acetylcholine
was expressed as the percentage of dilation of the active tone (preconstriction) 15,16.
Drugs
N-2-hydroxy-ethylpiperazine-N-2-ethylsulfonic acid (HEPES), ethylenbis-(oxyethylenenitrolo)  tetra-
acetic acid (EGTA), phenylephrine, acetylcholine, were purchased from Sigma (St. Louis, MO). Other
reagents were purchased from Prolabo (Paris, France). Drugs were dissolved and diluted in
physiological salt solution (HEPES buffer). Concentrations are expressed as final concentration of
each drug in the organ bath.
Statistical analysis
Data are expressed as mean ± SEM. Significance of the differences between groups was determined
by analysis of variance (ANOVA for consecutive measurements: responses to pressure, flow,
phenylephrine and acetylcholine). Means were compared by unpaired t test or Bonferroni’s test. P
<0.05 was considered to be statistically significant.
RESULTS
Body weight was not affected by the expression of the mutant protein (41±2 versus 39±2 g,
transgenic mice (line TgMa or TgVe) versus wild-type littermate, n= 8 to 12 per group). Mean arterial
blood pressure, measured in femoral artery, was not significantly different between transgenic and
wild-type mice (108.3 ±4.9, n= 6 in TgMa mice; 105.6±1.8, n=5 in TgVe mice and 111.6±2.7, n=5 in
wild-type mice).
Pressure-induced arterial tone
In isolated tail caudal arteries stepwise increases in intraluminal pressure from 0 to 50 mmHg induced
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5an increase in artery diameter, whereas further step increases in pressure induced no more increase or
a decrease in diameter reflecting the development of myogenic tone. The difference between passive
diameter and the diameter measured under physiological conditions was considered as myogenic tone
(Figure 1A). Myogenic tone was significantly increased in arteries from transgenic mice compared
with their wild-type littermates (Figure 1A). Myogenic tone, when normalized to the corresponding
passive diameters, was also significantly increased in arteries from transgenic mice compared with
their wild-type littermates (Figure 1B).
Isolated tail caudal arteries were also submitted to stepwise increases in intraluminal pressure, in a
Ca2+-free physiological salt solution containing EGTA (2 mM) and sodium nitroprusside (10 µM).
Under these conditions, arteries responded by a progressive rise in diameter. Internal diameter ranged
from 289.6 ± 16.4 µm (pressure, 25 mmHg) to 346.3 ± 20.1 µm (pressure, 150 mmHg) in control
mice. Passive arterial diameter curves were unaffected in transgenic mice as compared with their wild-
type littermates (Figure 1C).
Flow-induced responses
In arteries submitted to a pressure of 75 mmHg, increasing flow by step induced a progressive arterial
dilation. Arterial dilations were quantified as increases in diameter. Flow (shear stress)-induced
dilation was significantly reduced in caudal arteries from transgenic mice as compared with arteries
from wild-type mice (Figure 2A).
From the flow and diameter data obtained, wall shear stress was calculated and plotted against the
changes in arterial diameter. Figure 2B shows that a given step increase in wall shear stress elicits a
significantly attenuated increase in diameter of caudal arteries of transgenic mice compared with those
of wild-type mice.
Responses to vasoactive agents
We examined contraction of tail caudal arteries from transgenic and wild-type mice in response to
phenylephrine. All arteries contracted in a dose-dependent manner in response to phenylephrine.
Vasoconstriction in response to phenylephrine was similar in transgenic and wild type mice (Figure
3A).
To study vasorelaxation, precontraction was matched in arteries from transgenic and wildtype mice.
Acetylcholine induces an endothelium-dependent relaxation. Tail caudal arteries relaxed in a dose-
dependent fashion in response to acetylcholine. Responses to acetylcholine were not impaired in
transgenic mice as compared with their wild-type littermates (Figure 3B).
DISCUSSION
In this study we showed that transgenic mice expressing a CADASIL mutant Notch3 in vSMC
exhibited a significant increase in pressure-induced contraction and a significant decrease in flow-
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6induced dilation in isolated caudal arteries. Vascular dysfunction was detected in 10 month-old
transgenic mice, when mutant arteries exhibit disruption of adhesion of vSMC to neighboring
endothelial cells and vSMC as well as cytoskeleton abnormalities of vSMC characterized by an
increased number of dense plaques and dense bands1 1. In contrast phenylephrine-induced contraction
and acetycholine -induced dilation were unaffected in these transgenic mice, indicating that the
defective transduction of mechanical forces did not arise from a global dysfunction of vSMC.
Together the data indicate that transgenic mice exhibit a specific defect in the transduction of shear and
tensile stress into dilation and constriction respectively. Impaired mechanotransduction with preserved
agonist or receptor-induced tone has been previously reported in mice lacking vimentin or dystrophin
14,15. Thus our findings further support the notion that mechanical forces (flow, pressure) and chemical
stimuli act, at least in a great part, through different pathways 19-22.
The specific molecular basis for the mechanotransduction defect in Notch3 mutant arteries remains to
be elucidated. Both myogenic tone and flow-mediated dilation depend on cytoskeleton integrity and
cell to cell force transmission through the cytoskeleton, integrins and the extracellular matrix 12-17.
Previous works showed that pressure induced arterial tone involved an initial calcium entry into
arteriolar SMC, subsequent activation of signaling pathways (PKC, PLC, Rho-A..) that sensitized the
contractile apparatus to calcium and further resulted in the stimulation of actin polymerization in
vSMC17,19,20,22. Increased myogenic tone likely arises from a direct deleterious effect of mutant
Notch3, expression of which was specifically targeted in vSMC. Ultrastructural analyses are consistent
with an increased actin polymerization in SMC of mutant arteries1 1. In contrast impaired flow-induced
dilation, which primarily involves endothelial cells, likely results from an indirect effect of mutant
Notch3. Ultrastructural changes of endothelial cells have been detected in mutant arteries1 1.
Additionally, one might speculate that defective myoendothelial communications or even a chronic
change in smooth muscle tone could account for this specific endothelial cell dysfunction2 3. Additional
studies are required to address this issue.
Previous studies reported in CADASIL patients an impaired cerebral vasoreactivity, as determined by
attenuated vasodilation to inhaled carbon dioxide or acetazolamide and, abnormal vasoconstrictor
reactivity in isolated small gluteal arteries24-26. Of note, all three studies included essentially
symptomatic patients with a mean age above 45 years, an age where the pathological hallmarks of the
CADASIL arteriopathy, including GOM deposits, Notch3 accumulation and vSMC degeneration, are
already apparent. Thus these human studies have been difficult to interpret because it was unclear
whether impaired vasoreactivity had or not a primary responsibility in the pathogenic process and
whether it arose from vascular cells dysfunction or degeneration. In the present study, we demonstrate
that vascular mechanotransduction is very early impaired, before the appearance of the pathological
hallmarks of CADASIL. Thus, our findings suggest an early role of vascular dysfunction in the
pathogenic process of the disease.
Reduced cerebral blood flow has been demonstrated in CADASIL patients using positron emission
tomography, magnetic resonance imaging bolus tracking or phase contrast 24,27-30. Pressure and flow
H
AL author m
anuscript    inserm
-00137196, version 1
7are two mechanical stimuli that determine the basal vascular tone in resistance arteries and allow for a
rapid adaptation to changes in blood flow and pressure. Attenuation in flow-induced dilation might
lead to a lesser adaptation to increases in blood flow in organs when a metabolic need requires a
higher blood supply. Similarly, increased myogenic tone might lead to a lesser adaptation to decreases
in blood pressure. Because there is no organ in the body as dependent as the brain on a continuous
blood supply, defective mechanotransduction to shear and tensile stress might reduce cerebral blood
flow sufficiently to cause ischemic cell injury.
In conclusion, the present study provides the first evidence that vascular reactivity to the mechanical
factors, flow and pressure, is early and selectively impaired in arteries expressing a CADASIL mutant
Notch3. Treatments that improve vascular mechanotransduction could be beneficial in Notch3
mutation carriers at risk of developing the CADASIL disease.
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Figure 1: Diameter changes measured in response to pressure in isolated tail caudal arteries.
A-Changes in diameter in response to step increases in pressure (myogenic tone) in caudal arteries.
Myogenic tone is expressed as active tone (µm).
B- Myogenic tone expressed as percentage of passive diameter.
C- Passive diameter measurements were determined in a Ca2+-free isotonic salt solution containing
EGTA (2mmol/L) and in the presence of sodium nitroprusside (10µmol/L) in caudal arteries.
Caudal arteries were isolated from wild-type (n=12) and transgenic mice (n=9 and n=10, lines TgMa
and TgVe respectively).
*P <0.001; two-factor ANOVA, transgenic versus wild-type mice.
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Figure 2: Diameter changes measured in response to flow (shear stress) in isolated tail caudal arteries
A- Changes in diameter in response to stepwise increases in intraluminal flow were determined in
caudal arteries submitted to a pressure of 75mmHg and preconstricted with phenylephrine. Flow-
mediated dilation is expressed as percentage dilation of active tone by flow.
B- Flow-induced dilation (in µm change in diameter) is expressed as a function of shear stress.
Caudal arteries were isolated from wild-type (n=12) and transgenic mice (n=9 and n=10, lines TgMa
and TgVe respectively).
*P <0.001; two-factor ANOVA, transgenic versus wild-type mice.
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Figure 3: Concentration-dependent-contraction to phenylephrine (A) and concentration-dependent-
dilation to acetylcholine (B) in tail caudal arteries isolated from wild-type (n=12) and transgenic mice
(n=8 and n=9, lines TgMa and TgVe respectively). No significant difference; 2-factor ANOVA,
transgenic versus wild-type mice.
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